Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

510(k) Process Issues Surface At FDA Appropriations Hearings

This article was originally published in The Gray Sheet

Executive Summary

Deputy FDA Commissioner Joshua Sharfstein told Congress he and incoming Commissioner Margaret Hamburg will be taking a look at the 510(k) clearance process to determine whether it is truly flawed, or just misunderstood
Advertisement

Related Content

FDA Aims To Explain Itself Better With New Transparency Task Force
FDA Aims To Explain Itself Better With New Transparency Task Force
Device CEOs Fear New FDA Resources Will End Up On Food’s Plate
Device CEOs Fear New FDA Resources Will End Up On Food’s Plate
Do-Over? FDA Orders Look-Back At Knee Device 510(k) Review Process
Do-Over? FDA Orders Look-Back At Knee Device 510(k) Review Process
Obama Budget Would Boost FDA Device Program Funding 12.5%

Topics

Advertisement
UsernamePublicRestriction

Register

MT027463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel